Pooja Hingorani

Summary

Affiliation: Phoenix Children's Hospital
Country: USA

Publications

  1. pmc Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group
    Pooja Hingorani
    Division of Pediatric Hematology Oncology, Phoenix Children s Hospital, Phoenix, Arizona 85016, USA
    Pediatr Blood Cancer 57:939-42. 2011
  2. ncbi Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas
    Pooja Hingorani
    Division of Hematology, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    J Pediatr Hematol Oncol 34:524-7. 2012
  3. doi BIRC5 expression is a poor prognostic marker in Ewing sarcoma
    Pooja Hingorani
    Center for Cancer and Blood Disorders, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    Pediatr Blood Cancer 60:35-40. 2013
  4. doi Past, present and future of therapies in pediatric sarcomas
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Childrens Hospital, 1919 E Thomas Road, Phoenix, AZ 85003, USA
    Future Oncol 6:605-18. 2010
  5. doi Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Children s Hospital, Phoenix, Arizona 85016, USA
    Cancer 117:1764-74. 2011
  6. doi Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    Clin Cancer Res 15:3416-22. 2009
  7. doi Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Childrens Hospital, Phoenix, AZ 85003, USA
    Cancer Chemother Pharmacol 64:733-40. 2009
  8. doi Progress of oncolytic viruses in sarcomas
    Christina K Lettieri
    Center for Cancer and Blood Disorders, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    Expert Rev Anticancer Ther 12:229-42. 2012

Detail Information

Publications8

  1. pmc Body mass index (BMI) at diagnosis is associated with surgical wound complications in patients with localized osteosarcoma: a report from the Children's Oncology Group
    Pooja Hingorani
    Division of Pediatric Hematology Oncology, Phoenix Children s Hospital, Phoenix, Arizona 85016, USA
    Pediatr Blood Cancer 57:939-42. 2011
    ..We investigated the role of body mass index (BMI) on the incidence of surgical wound complications in patients with localized osteosarcoma treated on the Children's Oncology Group (COG) legacy trial, INT-0133...
  2. ncbi Gemcitabine, docetaxel, and bevacizumab in relapsed and refractory pediatric sarcomas
    Pooja Hingorani
    Division of Hematology, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    J Pediatr Hematol Oncol 34:524-7. 2012
    ..The outcome for patients with relapsed and refractory pediatric sarcomas remains dismal. Novel agents are needed to improve overall survival in these patients...
  3. doi BIRC5 expression is a poor prognostic marker in Ewing sarcoma
    Pooja Hingorani
    Center for Cancer and Blood Disorders, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    Pediatr Blood Cancer 60:35-40. 2013
    ..The goal of the current study was to evaluate the role of BIRC5 in Ewing sarcoma (ES), the second most common pediatric bone sarcoma...
  4. doi Past, present and future of therapies in pediatric sarcomas
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Childrens Hospital, 1919 E Thomas Road, Phoenix, AZ 85003, USA
    Future Oncol 6:605-18. 2010
    ..This article discusses the successes, the failures and the future direction of these therapies...
  5. doi Systemic administration of reovirus (Reolysin) inhibits growth of human sarcoma xenografts
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Children s Hospital, Phoenix, Arizona 85016, USA
    Cancer 117:1764-74. 2011
    ..Reolysin is an unmodified oncolytic reovirus that selectively replicates in Ras-activated cancer cells while not causing any significant human illness in its wild form...
  6. doi Inhibition of Src phosphorylation alters metastatic potential of osteosarcoma in vitro but not in vivo
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    Clin Cancer Res 15:3416-22. 2009
    ..We studied the effect of inhibition of Src phosphorylation in preventing the growth and development of pulmonary metastases in osteosarcoma...
  7. doi Preclinical activity of palifosfamide lysine (ZIO-201) in pediatric sarcomas including oxazaphosphorine-resistant osteosarcoma
    Pooja Hingorani
    Department of Pediatric Hematology Oncology, Phoenix Childrens Hospital, Phoenix, AZ 85003, USA
    Cancer Chemother Pharmacol 64:733-40. 2009
    ..In the current study, the activity of palifosfamide lysine (ZIO-201), a stable form of palifosfamide, was evaluated in a panel of sarcoma cell lines and tumor xenografts including oxazaphosphorine-resistant xenografts...
  8. doi Progress of oncolytic viruses in sarcomas
    Christina K Lettieri
    Center for Cancer and Blood Disorders, Phoenix Children s Hospital, Phoenix, AZ 85016, USA
    Expert Rev Anticancer Ther 12:229-42. 2012
    ..Further understanding of the antiviral immune response and a viral induced anti-tumor immune response will permit a maximization of oncolytic virotherapy...